• EverGen reveals Q2 2022 financials and key growth milestones for expansion across Canada
• Company acquired a 50% interest in Project Radius and a 67% interest in GrowTEC; agreed term sheet for CAD$31 million Senior Term Loan Facility with lenders Roynat and EDC
• EverGen remains primed for a catalyst-rich second half of 2022; appears on track to boost RNG production to satisfy Canada’s swelling demand as consumers flock to the renewable natural gas space

“We have positioned EverGen as a leading RNG platform with a core operating portfolio and pipeline of projects in Canada set to deliver significant RNG volumes and accelerate the energy transition,” were the words of Chase Edgelow, CEO of EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF) as the company reported financial results as at and for the three- and six-month periods ended June 30, 2022 (https://ibn.fm/CboZ3). Second quarter updates and highlights include milestones such as expansion across Canada, where the company now boasts a presence in three of the country’s four largest jurisdictions for RNG. Remaining laser-focused on its commitment to cater to the ballooning demand for renewable natural gas, EverGen has continued to execute its rapid growth strategy in Q2 2022. As a result, the company acquired a 50% interest in a portfolio of RNG development projects in Ontario called Project Radius – a strategic move that marks its inroad into Eastern Canada after establishing a notable RNG foothold in Western Canada. The construction of this late-stage portfolio of three high-quality, on-farm RNG projects with the combined capacity to produce approximately 1.7 million GJ/year of RNG is expected to continue throughout 2023 and 2024 (https://ibn.fm/1ng14). Following the acquisition of Project Radius, the company acquired a 67% interest in Alberta’s Grow the Energy Circle Ltd. (“GrowTEC”), a sustainable agriculture venture centered around a farm-scale biogas facility that converts biodegradable waste into biogas and generates renewable power. The project is currently in the first phase of a core RNG expansion expected to be completed in Q4 2022. EverGen will work with GrowTEC to expand facilities this year to process the biogas and upgrade it to RNG to be fed into the local pipeline network. With an offtake agreement secured with FortisBC, this project appears well positioned to reap the benefits from a long-term purchasing agreement with British Columbia’s largest energy provider. Offtakes are often key to ensuring that producers have guaranteed buyers for their future products and to helping them have better access to finance (https://ibn.fm/Mx07m). EverGen’s growth aspirations continued to achieve external validation throughout Q2 with new financing arrangements that ensure full funding of its near-term Core RNG Expansion Projects. The company signed a term sheet with Scotiabank’s subsidiary Roynat Capital and Export Development Canada for a $31 million syndicated senior term loan to support the funding of its Fraser Valley Biogas and Net Zero Waste Abbotsford projects. With an increasing number of consumers seeking RNG solutions in a bid to mitigate their carbon footprint, Chase is beaming with optimism about the company’s prospects for the rest of the year. “Having achieved key milestones in our core expansion projects, we have a clear path to deliver increased RNG production in excess of 2 million GJ per year and are primed for a catalyst-rich second half of 2022.”, he said as he revealed the company’s lofty goals for the future. For more information, visit the company’s website at www.EvergenInfra.com. NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

• Lexaria’s development of its patented DehydraTECH(TM) technology since 2014 has yielded 27 patents in Australia, the United States, the European Union, Japan, India and Mexico with approximately 50 additional patents pending around the world
• Its latest patent, granted in Mexico, applies a range of active ingredients, including but not limited to non-psychoactive cannabinoids and NSAIDs in a variety of ready-to-drink consumer retail beverage products
• Lexaria remains committed to advancing its research and expanding the indications and efficacy of its DehydraTECH technology, as it looks to benefit from the CBD industry, projected to be valued at $111.8 billion by 2030, and the cardiovascular drugs market, projected to be valued at $107.8 billion by 2025

Since Lexaria Bioscience (NASDAQ: LEXX) began the development of its industry-leading DehydraTECH(TM) technology back in 2014, the company has remained steadfast in its goal to improve the way active pharmaceutical ingredients (“APIs”) enter the bloodstream. Moreover, as a global innovator in drug delivery platforms, the company has not shied away from advancing its research to cut across various health conditions, including but not limited to hypertension, epilepsy, diabetes and dementia, among others. These efforts have yielded 27 granted patents around the world since 2014, with approximately 50 additional patents pending. It also has national filings in over 40 jurisdictions with the highest commercial potential, reflecting the company’s commitment to creating shareholder value and pushing its technology further into the market (https://ibn.fm/imFGA). Its latest patent, granted in Mexico under registration #390001, applies to a range of active ingredients, including but not limited to non-psychoactive cannabinoids and NSAIDs in a variety of ready-to-drink consumer retail beverage products. Additional claims granted to this patent also include the treatment of neurological diseases such as Parkinson’s disease, Human Immunodeficiency Virus (“HIV”), Alzheimer’s, and Schizophrenia (https://ibn.fm/Sni6V). Through its four subsidiary companies, Lexaria has explored various sectors such as cannabidiol for hypertension, oral nicotine for reduced risk and antiviral drugs for COVID-19 and other infectious diseases. The progress so far has also allowed them to sub-license its DehydraTECH technology worldwide for delivering fat-soluble active molecules and drugs, thereby increasing the number of people who benefit from this technology and the number of lives impacted by it. Lexaria remains committed to advancing its studies and expanding the indications and efficacy of its DehydraTECH technology. Through these efforts, it looks to benefit significantly from the CBD industry, projected to be valued at $111.8 billion by 2030 (https://ibn.fm/OP74n). In addition, Lexaria also looks to capitalize on the growing cardiovascular drugs market, which is projected to be valued at $107.8 billion by 2025, up from $96.1 billion in 2022 (https://ibn.fm/SWk5U). As it pushes for the approval of additional patents and the licensing of its technology, the company looks to grow its market share significantly while redefining drug delivery platforms. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• D-Wave has announced first ever demonstration of large-scale coherence in quantum annealers
• New research findings open the door to simulations of exotic phases of matter (unusual states of matter, outside of liquid, solid or gas, that make up the universe)
• The company is further exploring the potential of annealing quantum computing for future products, services, and software applications

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, is focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials science, drug discovery, scheduling, fault detection, and financial modeling, and is the only provider building both annealing and gate-model quantum computers. Through its products, the company is unlocking commercial use cases in optimization today while building the technologies that enable new solutions for tomorrow. Quantum annealing technology is a quantum computing method used to find the optimal solution to problems with many possible solutions by exploiting properties specific to quantum physics. Quantum annealing uses a cooling process, where the temperature is replaced by quantum energy, and the lowest energy state (global minimum), is found through the annealing process. D-Wave has demonstrated coherent evolution through a quantum phase transition in the paradigmatic setting of a 1D transverse field Ising chain, using up to 2,000 superconducting flux qubits in a programmable quantum annealer. The experiments conducted by the company, and recently published in Nature Physics, demonstrate that large-scale quantum annealers can be operated coherently and can pave the way to exploiting coherent dynamics in quantum optimization, machine learning, and simulation tasks. The company has concluded that by tuning the parameters of a programmable quantum annealer, it has simulated quantum critical phenomena in 1D chains of up to 2,000 spins. The results provide the foundation to support coherent quantum simulation on a previously unattainable scale. The experimental results give insight into coherence that is expected to support D-Wave’s development of annealing and gate-based quantum computers. D-Wave’s annealing and gate-based computing represent two different approaches to applying quantum technology to provide solutions to the problems being processed. The company’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 trust D-Wave’s quantum computing technology to solve some of their largest computational problems. D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO, and Lockheed Martin. The company boasts an extensive IP portfolio featuring over 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals. For more information on D-Wave’s customer success stories, visit https://www.dwavesys.com/learn/customer-success-stories/. The current commercial product offering of the company includes Advantage(TM) (fifth generation quantum computer), Leap(TM) (quantum cloud service), Launch(TM) (quantum computing onboarding service), and Ocean(TM) (full suite of open-source programming tools). For more information, visit the company’s website at www.DWavesys.com. NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Pharma, biotech, medical device, and health professionals are invited to attend the 2nd Investigator-Initiated Trials Summit on November 2-3, 2022 in Philadelphia. This summit provides an unmatched opportunity for discussions on engaging investigators, aligning research with organizational goals, designing and executing the best study protocols, and fostering collaboration. Attendees can learn ways of managing costs and securing operational support in investigator-initiated trials. Further, attendees can learn and network at three events for the cost of just one event ticket, since their registration also gains them entry to the 6th Digital Strategy & Innovation for Medical Affairs or the 3rd Next-Gen MSL Excellence summits. The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing B2B events. Important topics of discussion:

• Analyze the positive impact of collaborative research
• Gather insights on negotiating IIT and collaborative research global study contracts
• Explore the challenges in regulatory and compliance sectors
• Design a strong structure to sync RWE for added value
• Arrange the requisite oversight for managing multisite trials
• Plan strategies to support IIT projects
• Determine the company and investigator’s role in externally sponsored research

An impressive lineup of speakers will participate in keynote speeches, discussions, and fireside chats, sharing ways to overcome compliance and regulatory roadblocks in trials. Hear experts offering solutions for the challenges that hinder the discovery and safe development of effective therapies. At the summit, medical professionals and executives will discuss how to identify key elements within a contract and ways to accelerate negotiations. They will spotlight the best selection criteria for evaluating investigators and proposed IITs. Leaders will also educate the audience on the difference between company-sponsored publications and investigator-initiated publications. The group discussions will focus on finding solutions for common issues faced in managing IIT programs, and the networking opportunities offered during this summit will help companies establish important long-term ties. To learn more, please visit https://ibn.fm/4VuBr

• In recent interview, Stone Douglass, CEO and Chairman of GeoSolar Technologies, discusses how his prior work drove him to lead company that seeks to revolutionize how homes are electrified
• GeoSolar’s game-changing technology can provide cheaper, quieter, and more comfortable homes with better air quality
• As seasoned professional, Douglass appears confident that GeoSolar represents interesting investment opportunity amid major shift from fossil fuel-driven to clean, all-electric future — the transition he calls most important in human history

As energy transition gains momentum and a switch from carbon-based to clean electric living takes place, an attractive investment opportunity emerges for any company that tackles the climate crisis – believes Stone Douglass, CEO and Chairman of Colorado-based GeoSolar Technologies (“GST”) (https://ibn.fm/JXP2s). And Douglass should know a thing or two about spotting business opportunities as they emerge. At first sight, his career path may not seem typical for a person in charge of a company seeking to revolutionize how we heat, cool, cook, and power homes with 100% sustainable energy sources. Seemingly unrelated, his beginnings were on Wall Street, where he worked towards an investment banking career. But this experience gave him a unique opportunity to work with a broad range of small companies and broaden his expertise across different verticals. As he worked with a myriad of small companies – for which he claims there were virtually no two from the same business – he soon developed what appears to be a sophisticated commercial sense that can differentiate between compelling business opportunities and ones that are not. He found success in assisting companies to turn things around and become valuable for their shareholders, which helped him realize that there was a recurring theme at play when it comes to struggling businesses. “They didn’t have a clear definition of what their market is and how to sell the product profitably to that market. They were tackling it based on their expertise of the product without analyzing the receptiveness of the market,” he explained. This valuable experience allowed him to sharpen his cross-sectoral understanding of what works in business, so when he was introduced to GeoSolar Technologies, he was quick to recognize the Company’s growth potential. However, to continue the revolution that Douglass believed could change the world as we know it, the Company needed his financial expertise to capitalize on this growing market opportunity – and that’s when he joined as CEO and Chairman of the board. The electric home is far superior to fossil fuel-powered homes – it’s cheaper, quieter, and more comfortable, with better air quality. It’s a win for everyone — except the utilities and oil companies, Douglass is confident. And not less important, electric homes tend to be more valuable on resale. Against this backdrop, it is no surprise that the number of consumers seeking to switch to greener alternatives has exploded. A recent survey conducted by the renowned Pew Research Center reports that a whopping 69% of U.S. respondents prioritize developing alternative energy sources, including wind and solar, over expanding the production of oil, coal, and natural gas (https://ibn.fm/8QPHT). With only about 1% of the new homes in the U.S. built as zero-carbon or electric, there appears to be a vast, untapped market opportunity as consumers begin to demand clean energy sources and home builders start catching up to be able to respond to this swelling demand. SmartGreen home offers homeowners healthier carbon-free living, zero or no utility bills, and a healthier living environment that includes the 24/7 circulation of fresh air continuously filtered and adjusted for CO2/oxygen ratios. “We believe GST represents an extremely interesting investment opportunity for someone that is looking to help with the climate crisis and be involved in a company that can be extremely rewarding for its shareholders. ​​The first thing anyone that is looking at GeoSolar Technologies as an investment should understand is that the world is in the very early stages of what many think is the most important transition in human history- the switch from a fossil fuel-driven economy to a clean all-electric future — often referred as The Electric Revolution”, concludes Douglass confidently. For more information on GeoSolar’s Regulation A+ capital raise, please visit https://www.manhattanstreetcapital.com/geosolar-technologies-inc. For more information, visit the company’s website at www.GeoSolarPlus.com. NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

• For the quarter that ended June 30, 2022, Reklaim’s year-to-date revenue was up 216% over the same period in the prior year
• During that same quarter, revenue increased 65% over the prior quarter that ended March 31, 2022
• Reklaim grew its B2B customer base by 51% during the quarter that ended June 30, 2022
• The company has 320 million consented consumer profiles
• Reklaim is integrated with 15 of the largest global platforms that sell and distribute data

Reklaim (TSX.V: MYID) (OTCQB: MYIDF) offers a privacy-compliant identity ecosystem both online (www.ReklaimYours.com) and via a mobile app on iOS and Android in the U.S and Canada. Reklaim believes that consumers own their data and, consequently, have the right to access their online data and choose how it is used, whether for compensation or privacy. Reklaim gives consumers visibility regarding how their data is collected and compensates them for its use, all while also providing advertisers and brands with a source of data compliant with emerging privacy regulations. The company is driven by the evolution of privacy and how it impacts consumers and companies. Reklaim sells compliant, zero-party data to Fortune 500 brands, platforms, and data companies so that they can offset the risk of non-compliance. ‘Zero-party data’ is data that a consumer proactively and intentionally shares with an organization. This contrasts with ‘third-party data,’ which organizations have collected unbeknownst to consumers for more than 20 years. Zero-party data is the most valuable data in the US$200B data market, as it provides organizations with explicit consumer opt-in vs. through an intermediary such as a data broker. Reklaim empowers consumers to take back control of their data. The company allows consumers to visit the platform, confirm their identity, and uncover their data that has been collected and sold for years without their explicit consent. Consumers can add, edit or delete data that is associated with their profile and choose which pieces of data they would be willing to share for weekly compensation. Reklaim is the only company in the world today providing consumers with both access to their data that is circulating in the market and a guaranteed weekly paycheck. Alternatively, for users who do not want to sell their data, users can choose to protect their data and subscribe to a suite of subscription-based (“SaaS”) privacy tools that obfuscate the location of their device when browsing on a mobile phone and alert them when a third-party source has leaked their data or passwords. Reklaim was founded in 2018 and is based in New York, with offices in Toronto. Business Model Reklaim’s primary revenue-generating operations stem from selling consented consumer data to companies and resellers that need data that is compliant with all applicable consumer privacy laws and regulations, including the California Consumer Privacy Act (“CCPA”). Major Fortune 500 customers and enterprise data platforms have validated Reklaim’s zero-party data and have added this data to their marketplaces and decision-making. Reklaim has sales across three core verticals: brands and agencies that buy advertising, platforms that sell data to Fortune 500 clients, and companies whose primary business is selling data to business customers.

• Companies & Agencies that Buy Advertising – These customers use Reklaim’s compliant data to inform their media decisions in social, connected television, programmatic and other verticals. Sales cycles are short at about 30 days. Reklaim customers in this segment are Microsoft, Amgen, Bayer, UPS, and Hasbro, to name a few.
• Platforms that Sell Data – Reklaim has integrated its zero-party data into 15 of the largest enterprise data platforms in the world. These platforms act as the ‘grocery stores’ of data, where the Fortune 500 come to make their data purchases. Reklaim’s data has been validated and added to these platforms, providing ubiquitous distribution of Reklaim data across the data ecosystem. Due to data quality verification and technical requirements, sales cycles are typically longer, about 60-90 days. Customers include LiveRamp, Transunion, Google, The Trade Desk, Lotame, and T-Mobile.
• Data Companies that Sell Data – These customers need to purchase compliant data to continue offering data to their clients. Sales cycles often last 90-120 days, but these contracts are typically annual, have the highest value, and auto-renew. An example is Nielsen, the television measurement company.

Market Outlook The data industry, valued at $245 billion in the U.S. and more than $400 billion globally, is being disrupted, and Reklaim is positioned to benefit from the destructive shift. The disruption is driven by two factors: (1) technology is reducing access to core data that the industry has become dependent upon, and (2) government intervention is emerging through laws and regulations intended to protect consumer data privacy. Over the past 20 years, the data industry has harvested and exploited consumer data without consumers’ express consent. However, the legal and regulatory environment surrounding consumer data acquisition is rapidly evolving, placing the consumer at the center of emerging privacy policies. The European Union’s General Data Protection Regulation (“GDPR”) was rolled out in 2019, followed shortly by the CCPA and the California Privacy Rights Act. More recently, the Canadian Privacy Protection Act, Brazil’s General Data Protection Law, India’s Information Technology Act, and South Africa’s Protection of Personal Information have continued the trend. As a result, industries and companies currently relying on unconsented consumer data will experience a regulation-driven disruptive migration, forcing them sooner rather than later to use only fully consented data sources. This consumer data environment is driving companies to Reklaim to replace their current data providers. While privacy policies continue to iterate to include the consumer, Big Tech, namely Apple and Google, are increasingly removing data from the market that brands and companies have relied on. Apple’s introduction of Advanced Ad Tracing (“ATT”) has impacted companies’ ability to track consumer behavior across applications. Facebook, in Q4 2021, was forced to accept a US$10B write down on revenue projections due to this change and is expecting a similar US$10B right down again in 2022. Google is making similar changes, the most significant being the removal of the third-party cookie from its Chrome browser, which has a 65% market share. This third-party cookie is responsible for the tracking that websites use to monetize by tracking consumers. The removal of the Chrome cookie will put the 1.8 billion websites operating in the open web today under pressure to find a solution to replace the 65% loss in revenue. Management Team Neil Sweeney is Chairman and CEO of Reklaim. He has more than 20 years in the industry, with an established reputation for visionary entrepreneurship and an ability to develop technologies. Technologies Sweeney created are used by Fortune 500 brands like Coca-Cola, Lowe’s, Walmart, General Motors, Unilever, and Mondelez. They are the core component of top media demand-side platforms, including Adelphic, The Trade Desk, AppNexus, MediaMath, and Triton Media. He is a two-time finalist for Ernst & Young’s ‘Entrepreneur of the Year’ and received Deloitte’s ‘Fast 50’ award for three consecutive years for the growth of organizations he created. Ira Levy is CFO at Reklaim. He has over 15 years of experience in a wide range of high-growth, early-stage public and private companies. Most recently, he held the roles of Corporate Controller at VIVO Cannabis Inc. (TSX: VIVO) and Senior VP/Head of Finance for start-up Honest Inc. (d/b/a Province Brands of Canada). He has also acted as an advisor for startup AI companies through the Creative Destruction Lab Program. He received his MBA in Accounting and Finance from the Schulich School of Business at York University and is a Chartered Professional Accountant. Jake Phillips is Chief Technical Officer at Reklaim. He is a proven technology leader who excels at bridging the gap between innovation and business in dynamic environments. He has gained a breadth of industry knowledge across telco/cable, banking, and client services. His professional experience spans enterprise integration, mobility, big data, cloud operations, and data security. For more information, visit the company’s website at www.ReklaimYours.com. NOTE TO INVESTORS: The latest news and updates relating to MYIDF are available in the company’s newsroom at https://ibn.fm/MYIDF

• Correlate Infrastructure Partners Inc. is a Louisiana-based developer of energy use solutions that is focused on providing data-driven energy analysis and advisement to commercial real estate developers
• Correlate recently announced that it is partnering with Ultra Yield Solutions (“UYS”) to improve energy use services to indoor horticultural growers
• The indoor horticultural industry, also known as controlled environment agriculture or CEA, is rising in popularity thanks to consumer efforts to promote locally grown produce year-round
• Under the partnership, UYS will take care of clients’ professional indoor farming LED design needs while Correlate will handle the solar, storage, and funding solutions

Indoor horticulture, also known as controlled environment agriculture or CEA, is increasing in popularity as consumer demand for produce grown closer to home under year-round, clean-control conditions continues to rise. The market sustaining CEA produce is predicted to increase at a CAGR of 10.9 percent from 2021 to 2028, according to Research and Markets analysts cited in an AgriTech Tomorrow report earlier this year (https://ibn.fm/ri7kc). As the demand for indoor-grown produce increases, the need for energy-efficient CEA-friendly lighting is also on the rise according to the AgriTech Tomorrow report, highlighting efforts to power what for many is becoming a passion project. Correlate Infrastructure Partners (OTCQB: CIPI), a company focused on reducing climate change through improving the ways commercial buildings use energy, announced recently that it is entering the CEA space thanks to a partnership the company inked with horticulture lighting distributor Ultra Yield Solutions (“UYS”). “We are excited to see this partnership transform the CEA space by dramatically reducing the operating costs of urban indoor farming. It will enable operators to reach profitability faster while simultaneously increasing the sustainability and resilience of their businesses,” Correlate’s VP of Sales Jim Fiorentino stated in the Sept. 7 announcement (https://ibn.fm/zoWA3). “We intend to make it simple and cost-effective for sustainably-minded growers to live their values by incorporating clean energy solutions into their operations.” Under the partnership, UYS will focus on the clients’ professional indoor farming LED design needs, bringing the company’s deep industry experience to the table, while Correlate will take care of the solar, storage and funding as needed. Correlate’s platform advances clean electrification solutions through locally sited solar, energy storage, EV infrastructure and data-driven efficiency measures that are powered by the company’s proprietary analytics. Commercial industries have increasingly focused on transparency in their environmental, social and governance (“ESG”) reporting as a way of helping consumers evaluate the appeal of a particular business in a competitive industry, using a measurable standard as a base for their judgment. Climate change worries have driven new awareness of trends involving severe weather, and the United Nations’ successful Paris convention on climate change less than a decade ago has spurred government and international agency policies on reducing greenhouse gas emissions. Research technology company Glow’s analysts found recently that 1 in 4 consumers in the United States, Australia and the United Kingdom cited sustainability and social responsibility factors as a motivator for starting, stopping or switching use of a brand. For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• House Concurrent Resolution 102, co-sponsored by Congresswoman Rashida Tlaib and Congressman Jamaal Bowman, seeks to change how streaming services pay royalties to artists
• Friendable’s 360-degree Fan Pass Live artist platform supports production, distribution, and marketing, with all earned revenue going to the artist
• Fan Pass Live is a large aggregator of artist data, with enterprise-level services on track to become the largest data and content funnel in the industry today

There is a lack of transparency in music streaming services like Spotify, Amazon Music, Apple Music, and YouTube, creating an environment dominated by private deals with powerful corporations, predatory pricing, and other practices that would otherwise be illegal in the traditional music industry landscape. Even the largest streaming service in the world, Spotify, paid rights holders at a rate of $0.0030, a rate that would require 800,000 monthly streams for an artist to make the equivalent of a full-time worker at $15 per hour. According to the UN’s World Intellectual Property Organization, these rates are declining yearly. Congresswoman Rashida Tlaib of Michigan’s 13th District has co-sponsored House Concurrent Resolution 102 with Congressman Jamaal Bowman of New York’s 16th District, which proposes a new resolution recognizing the need to establish new royalty programs that directly compensate musicians through fair royalty payment every time their music is listened to on streaming services (https://ibn.fm/cVp6L). “Artists are making well below a penny per stream, and too many are not able to make ends meet. Detroit is one of the centers of the music world, the birthplace of Motown and techno, and so much more, and we are home to thousands of musicians and artists who deserve fair compensation for their labor,” the congresswoman commented. “This resolution is about sending the message that Congress isn’t going to tolerate artists being taken advantage of anymore.” Friendable (OTC: FDBL), a mobile technology company focused on their Fan Pass Live artist platform, recognizes the importance of providing musicians resources that help them further their careers instead of hindering them. In January 2022, the company completed the acquisition of Artist Republik and FeaturedX, creating the ultimate 360-degree music artist platform that supports production, distribution, and marketing – with revenues directed back to the music artist. Created by musicians for musicians, Fan Pass Live offers the support that artists need and are not generally afforded in this competitive industry dominated by big-name labels. The 360-degree music artist platform provides the support and tools that musicians need and includes:

• Music distribution and management
• Music production assistance
• Press release and Instagram promotion
• Digital storefront activation
• Artist marketplace for collaboration
• Merchandise, logo, and promotional design support
• Virtual concert booking and ticketing mobile streaming service
• Live streaming support
• Revenue from fan tips, monthly artist contests, merchandise, and ticket sales
• Access to fan data and performance analytics
• Monthly artist contests
• NFT development and Metaverse performances – coming soon

Fan Pass Live, including Artist Republik and FeaturedX, provides music artists with a one-stop shop for artists to grow their audience, interact with fans, promote their music, showcase their work, sell merchandise, and generate revenue. The company has created a large artist data aggregation platform, with enterprise-level services on track to become the largest data and content funnel in the industry today. With artists feeling a lack of support and being controlled by the industry labels, Fan Pass Live’s 360-degree music artist platform offers a solution to the problem in the industry today, giving artists back control of their music while they get paid for it. The platform aligns with the efforts of Congresswoman Tlaib and Congressman Bowman, who are looking to shift the music industry and how artists get paid for their hard work. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Odyssey Health is a medical company focused on unique, life-saving medical products that offer clinical advantages to unmet clinical needs
• The company is currently developing a treatment for concussion, a condition that currently does not have an FDA-approved treatment despite having both short- and long-term consequences
• Through animal studies, Odyssey has so far evidenced that PRV-002 can easily cross the blood-brain barrier to rapidly eliminate the swelling, oxidative stress, and inflammation in the brain caused by concussion while simultaneously restoring proper blood flow
• Odyssey is currently undertaking Phase 1 clinical studies with plans underway to commence its Phase 2 trial in due course

Toward the late 2000’s, Arizona Cardinals’ then-quarterback Kurt Warner made an interesting observation. During the 2007 season, the training and medical staff had given him a brace for his left arm when he tore a ligament, with this immediate intervention allowing him to play just a week later. Two years later, Kurt sustained a concussion, but this time the same staff could not offer a solution and only recommended rest. As a result, Kurt ended up missing the following week’s game. “The idea that there was treatment for an elbow injury – or an ankle, knee, hip, etc. – and not one for a brain injury always struck Warner as off, perhaps even ironic,” writes an article in AZ Central (https://ibn.fm/tGkcX). This observation, coupled with his experience with concussion, motivated Kurt to become involved in a company developing a drug candidate, PRV-002, that could be given to concussed patients to prevent both short-term and long-term consequences of concussion. Early last year, PRV-002 was sold to Odyssey Health (OTC: ODYY), a medical company focused on unique, life-saving medical products that offer clinical advantages to unmet clinical needs, with this transaction only boosting the former NFL player’s efforts even further because Odyssey formed the Sports Advisory Board (“SAB”) whose inaugural members included Kurt, fellow pro-NFL player Brett Favre, Mark Rypien, David Ross, and Steve Mariucci. “Each of these new members has been directly affected by traumatic brain injury and has first-hand experience of its effects on health and quality of life,” said Odyssey CEO Michael Redmond of the SAB’s formation (https://ibn.fm/hXCPA). “Concussion is a major health issue not only in sports but also in the military and everyday life. Our sports advisory board will play an integral role in enhancing the public’s awareness and understanding of the impacts of this common condition for which there is currently no FDA-approved drug treatment.” It is estimated that between 64 and 74 million new cases of traumatic brain injury (“TBI”) globally are reported every year (https://ibn.fm/hIUhZ). A majority of these cases, between 70% and 90%, are mild (“mTBI”), although this range is often considered an underestimation, according to various studies (https://ibn.fm/rVrdv). Also known as concussion, mTBI is caused by a jolt, blow, or force to the head that changes the brain’s function. This change often results in myriad consequences ranging from emotional and somatic changes to cognitive impairment and physical symptoms. These effects, an article by the Concussion Alliance explains, result from, among other things, the disrupted communication between neurons in the brain due to damage to the neuronal connections, chemical imbalance that requires lots of energy to return to the original state, and decrease in blood flow to the brain that, in turn, prevents adequate glucose from traveling to the brain (https://ibn.fm/NGYH4). In most cases, concussion symptoms resolve within a few days or weeks as the damaged pathways rebuild and strengthen through repetition, use and cleanup of cell debris. However, there has been growing concern that mTBI may be associated with long-term consequences, particularly due to repeated or multiple head impacts. According to the Center for Disease Control (“CDC”) (https://ibn.fm/IUscv), a person with a history of repeated mTBIs may “experience a longer recovery or more severe symptoms [or] may have long-term problems, including ongoing problems with concentration, memory, headache, and occasionally, physical skills, such as keeping one’s balance.” Ongoing research also shows that repeated episodes of concussion potentially cause chronic traumatic encephalopathy (“CTE”), a progressive brain condition that can only be diagnosed after death. New research has, in fact, found that contact-sport athletes are at least 68 times more likely to develop CTE than those who did not play any contact sport (https://ibn.fm/7FPrC). Moreover, CTE has been found in more than half of sportspeople who donated brains, according to findings by the Australian Sports Brain Bank (https://ibn.fm/BGQTS). It comes as no surprise, therefore, that retired sportspersons, such as the members of Odyssey’s SAB, are at the forefront of the pursuit of concussion treatment. Odyssey has so far evidenced, through animal studies, that PRV-002 can easily cross the blood-brain barrier to rapidly eliminate swelling, oxidative stress, and inflammation in the brain caused by concussion while simultaneously restoring proper blood flow. The drug is intended to be administered immediately after a concussive episode, effectively mitigating the effects a blow or jolt might have on the brain and its functions. The company is currently undertaking a human clinical Phase 1 trial evaluating the safety and tolerability of the drug candidate in healthy volunteers. It is also preparing for the planned Phase 2 study and working with its Military Advisory Board to identify clinical sites for this potentially groundbreaking study. For more information, visit the company’s website at www.OdysseyHealthInc.com. NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY

• Yakima, Wash.-based CubCrafters Inc. has proven its brand over 42 years of designing, building and testing light aircraft inspired by the legacy of the classic Piper PA-18 Super Cub
• The company also produces experimental aircraft with DIY optional kits for pilots who want the thrill of building their own aircraft
• CubCrafters recently announced its application make a public stock offering under a Regulation A exemption, aiming to raise $50 million
• The company reported reservations for $5 million worth of shares within just the first 48 hours, pending qualification with the SEC

World War II fighter pilot John Gillespie Magee Jr. only lived to be 19 years old but immortalized his name with a well-known sonnet about the joys of airplane flight, writing in 1941 that he had “slipped the surly bonds of Earth And danced the skies on laughter-silvered wings,” and in the “high untrespassed sanctity of space, Put out (his) hand, and touched the face of God” (https://ibn.fm/CKTFm). The poem evokes the love of flying many aviators and would-be aviators continue to feel nearly a century later, driving them “Up, up the long, delirious burning blue” on wings of aerospace-grade aluminum alloy. Yakima, Washington based aircraft manufacturer CubCrafters, is helping to inspire a new generation of aviators by participating as a sponsor in the General Aviation Manufacturers Association (“GAMA”) 2022 Aviation Design Challenge. In this program, high school students from across the country competed in modifying the design of a CubCrafters NXCub to fly from Seattle to Packwood, Wash., to efficiently deliver a maximum payload. In August the winning team from New York was awarded an all-expenses-paid aviation manufacturing experience to visit CubCrafters’ headquarters as well as Boeing, Signature Aviation, and other facilities in Washington (https://ibn.fm/IXIjQ). Also in August, CubCrafters announced that in the first 48 hours after informing the investment community of its Reg A funding plan, it attracted $5 million in reservations for 1 million potential shares of stock, pending qualification by the Securities and Exchange Commission (“SEC”). “Reservations for over 10 percent of our $50 million goal in only two days is just amazing. This level of interest from the aviation community and the general public tells us that they see real value in our company and want to help it grow,” CubCrafters’ VP of Sales Brad Damm stated (https://ibn.fm/lgXrr). “Backcountry aviation is increasing in popularity, and the demand for our aircraft continues to grow.” The company is aiming to speed up its production, improve its service capabilities and advance new innovation efforts, Damm said. CubCrafters has been producing its fleet of aircraft building from the legacy of the classic Piper PA-18 Super Cub for 42 years. The company has grown to develop its own new designs in the Experimental, LSA, and Part 23 Certified aircraft categories. CubCrafters’ future looks to be bright with this diverse offering of capable and modern aircraft, its partnerships fostering the next generation of aerospace professionals, and its innovative use of the Regulation A exemption public offering to meet the growing demand for its products and services. For more information, visit the company’s website at www.CubCrafters.com. NOTE TO INVESTORS: The latest news and updates relating to CubCrafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB